Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2008

01-06-2008

Infections and Autoimmunity: A Panorama

Authors: V. Pordeus, M. Szyper-Kravitz, R. A. Levy, N. M. Vaz, Y. Shoenfeld

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2008

Login to get access

Abstract

For more than 2,000 years, it was thought that malignant spirits caused diseases. By the end of nineteenth century, these beliefs were displaced by more modern concepts of disease, namely, the formulation of the “germ theory,” which asserted that bacteria or other microorganisms caused disease. With the emergence of chronic degenerative and of autoimmune diseases in the last century, the causative role of microorganisms has been intensely debated; however, no clear explanatory models have been achieved. In this review, we examine the current available literature regarding the relationships between infections and 16 autoimmune diseases. We critically analyzed clinical, serological, and molecular associations, and reviewed experimental models of induction of and, alternatively, protection from autoimmune diseases by infection. After reviewing several studies and reports, a clinical and experimental pattern emerges: Chronic and multiple infections with viruses, such as Epstein–Barr virus and cytomegalovirus, and bacteria, such as H. pylori, may, in susceptible individuals, play a role in the evolvement of autoimmune diseases. As the vast majority of infections pertain to our resident microbiota and endogenous retroviruses and healthy carriage of infections is the rule, we propose to focus on understanding the mechanisms of this healthy carrier state and what changes its configurations to infectious syndromes, to the restoration of health, or to the sustaining of illness into a chronic state and/or autoimmune disease. It seems that in the development of this healthy carriage state, the infection or colonization in early stages of ontogenesis with key microorganisms, also called ‘old friends’ (lactobacilli, bifidobacteria among others), are important for the healthy living and for the protection from infectious and autoimmune syndromes.
Literature
1.
go back to reference Nutton V (2005) The fatal embrace: Galen and the history of ancient medicine. Sci Context 18:111–121PubMedCrossRef Nutton V (2005) The fatal embrace: Galen and the history of ancient medicine. Sci Context 18:111–121PubMedCrossRef
2.
go back to reference De Flora S, Quaglia A, Bennicelli C, Vercelli M (2005) The epidemiological revolution of the 20th century. FASEB J 19:892–897PubMedCrossRef De Flora S, Quaglia A, Bennicelli C, Vercelli M (2005) The epidemiological revolution of the 20th century. FASEB J 19:892–897PubMedCrossRef
3.
go back to reference Shoenfeld Y, Rose NR (2004) Infection and autoimmunity, 1st edn. Elsevier, Amsterdam Shoenfeld Y, Rose NR (2004) Infection and autoimmunity, 1st edn. Elsevier, Amsterdam
4.
go back to reference Ramos-Casals M, Jara LJ, Medina F et al (2005) Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257:549–557PubMedCrossRef Ramos-Casals M, Jara LJ, Medina F et al (2005) Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med 257:549–557PubMedCrossRef
5.
go back to reference Yamazaki M, Kitamura R, Kusano S et al (2005) Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein–Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren’s syndrome patients with pulmonary involvements. Clin Exp Immunol 139:558–568PubMedCrossRef Yamazaki M, Kitamura R, Kusano S et al (2005) Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein–Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren’s syndrome patients with pulmonary involvements. Clin Exp Immunol 139:558–568PubMedCrossRef
6.
go back to reference Pender MP (2004) Epstein–Barr virus and autoimmunity. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam Pender MP (2004) Epstein–Barr virus and autoimmunity. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam
7.
go back to reference Severin MC, Shoenfeld Y (2004) Parvovirus B19 infection and its association with autoimmune disease. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam Severin MC, Shoenfeld Y (2004) Parvovirus B19 infection and its association with autoimmune disease. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam
8.
go back to reference Lundqvist A, Isa A, Tolfvenstam T, Kvist G, Broliden K (2005) High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol 33:71–74PubMedCrossRef Lundqvist A, Isa A, Tolfvenstam T, Kvist G, Broliden K (2005) High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol 33:71–74PubMedCrossRef
9.
go back to reference Subair H, Tiwana H, Fielder M et al (1995) Elevation in anti-proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 22:1825–1828PubMed Subair H, Tiwana H, Fielder M et al (1995) Elevation in anti-proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. J Rheumatol 22:1825–1828PubMed
10.
go back to reference Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford, England) 44:1433–1441CrossRef Newkirk MM, Goldbach-Mansky R, Senior BW, Klippel J, Schumacher HR Jr, El-Gabalawy HS (2005) Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Rheumatology (Oxford, England) 44:1433–1441CrossRef
11.
go back to reference Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, Hirota K, Tanaka S, Nomura T, Miki I, Gordon S, Akira S, Nakamura T, Sakaguchi S (2005) A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. JEM 201:949–960CrossRef Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, Hirota K, Tanaka S, Nomura T, Miki I, Gordon S, Akira S, Nakamura T, Sakaguchi S (2005) A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. JEM 201:949–960CrossRef
12.
go back to reference Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A (2006) Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology 118:233–239PubMedCrossRef Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A (2006) Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Immunology 118:233–239PubMedCrossRef
13.
go back to reference Quinones MP, Jimenez F, Martinez H et al (2006) CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium. J Mol Med (Berlin, Germany) 84:503–512 Quinones MP, Jimenez F, Martinez H et al (2006) CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium. J Mol Med (Berlin, Germany) 84:503–512
14.
go back to reference Yamanishi S, Iizumi T, Watanabe E et al (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74:248–256PubMedCrossRef Yamanishi S, Iizumi T, Watanabe E et al (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74:248–256PubMedCrossRef
15.
go back to reference Rocha F (2006) Protective role of helminthiasis in the development of autoimmune diseases. Clin Dev Immunol 13:159–162PubMedCrossRef Rocha F (2006) Protective role of helminthiasis in the development of autoimmune diseases. Clin Dev Immunol 13:159–162PubMedCrossRef
16.
go back to reference Kato I, Endo-Tanaka K, Yokokura T (1998) Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 63:635–644PubMedCrossRef Kato I, Endo-Tanaka K, Yokokura T (1998) Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 63:635–644PubMedCrossRef
17.
go back to reference Costalonga M, Hodges JS, Herzberg MC (2002) Streptococcus sanguis modulates type II collagen-induced arthritis in DBA/1J mice. J Immunol 169:2189–2195PubMed Costalonga M, Hodges JS, Herzberg MC (2002) Streptococcus sanguis modulates type II collagen-induced arthritis in DBA/1J mice. J Immunol 169:2189–2195PubMed
18.
go back to reference Schattner A (2005) Cosequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876–3886PubMedCrossRef Schattner A (2005) Cosequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876–3886PubMedCrossRef
19.
go back to reference Tishler M, Shoenfeld Y (2004) Vaccination may be associated with autoimmune diseases. IMAJ 6:430–432PubMed Tishler M, Shoenfeld Y (2004) Vaccination may be associated with autoimmune diseases. IMAJ 6:430–432PubMed
20.
go back to reference Tinazzi E, Ficarra V, Simeoni S, Artibani W, Lunardi C (2006) Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 26:481–488PubMedCrossRef Tinazzi E, Ficarra V, Simeoni S, Artibani W, Lunardi C (2006) Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 26:481–488PubMedCrossRef
21.
go back to reference Vasudev M, Zacharisen MC (2006) New onset rheumatoid arthritis after anthrax vaccination. Ann Allergy Asthma Immun 97:110–112CrossRef Vasudev M, Zacharisen MC (2006) New onset rheumatoid arthritis after anthrax vaccination. Ann Allergy Asthma Immun 97:110–112CrossRef
22.
go back to reference Shoenfeld Y, Aron-Maor A (2000) Vaccination and autoimmunity—‘vaccinosis’: a dangerous liaison? J Autoimmun 14:1–10PubMedCrossRef Shoenfeld Y, Aron-Maor A (2000) Vaccination and autoimmunity—‘vaccinosis’: a dangerous liaison? J Autoimmun 14:1–10PubMedCrossRef
23.
go back to reference DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63:839–844PubMedCrossRef DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63:839–844PubMedCrossRef
24.
go back to reference Levin LI, Munger KL, Rubertone MV et al (2005) Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J Am Med Assoc 293:2496–2500CrossRef Levin LI, Munger KL, Rubertone MV et al (2005) Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J Am Med Assoc 293:2496–2500CrossRef
25.
go back to reference Haahr S, Hollsberg P (2006) Multiple sclerosis is linked to Epstein–Barr virus infection. Rev Med Virol 16:297–310PubMedCrossRef Haahr S, Hollsberg P (2006) Multiple sclerosis is linked to Epstein–Barr virus infection. Rev Med Virol 16:297–310PubMedCrossRef
26.
go back to reference Bagos PG, Nikolopoulos G, Ioannidis A (2006) Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler (Houndmills, Basingstoke, England) 12:397–411CrossRef Bagos PG, Nikolopoulos G, Ioannidis A (2006) Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler (Houndmills, Basingstoke, England) 12:397–411CrossRef
27.
go back to reference Kissler H (2001) Is multiple sclerosis caused by a silent infection with malarial parasites? A historico-epidemiological approach: part I. Med Hypotheses 57:280–291PubMedCrossRef Kissler H (2001) Is multiple sclerosis caused by a silent infection with malarial parasites? A historico-epidemiological approach: part I. Med Hypotheses 57:280–291PubMedCrossRef
28.
go back to reference Rubio N, Sanz-Rodriguez F, Lipton HL (2006) Theiler’s virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell Immunol 239:31–40PubMedCrossRef Rubio N, Sanz-Rodriguez F, Lipton HL (2006) Theiler’s virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell Immunol 239:31–40PubMedCrossRef
29.
go back to reference Croxford JL, Olson JK, Anger HA, Miller SD (2005) Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J Virol 79:8581–8590PubMedCrossRef Croxford JL, Olson JK, Anger HA, Miller SD (2005) Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. J Virol 79:8581–8590PubMedCrossRef
30.
go back to reference Merkler D, Horvath E, Bruck W, Zinkernagel RM, Del la Torre JC, Pinschewer DD (2006) “Viral deja vu” elicits organ-specific immune disease independent of reactivity to self. J Clin Invest 116:1254–1263PubMedCrossRef Merkler D, Horvath E, Bruck W, Zinkernagel RM, Del la Torre JC, Pinschewer DD (2006) “Viral deja vu” elicits organ-specific immune disease independent of reactivity to self. J Clin Invest 116:1254–1263PubMedCrossRef
31.
go back to reference Oldstone MB, von Herrath M, Evans CF, Horwitz MS (1996) Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 206:67–83PubMed Oldstone MB, von Herrath M, Evans CF, Horwitz MS (1996) Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. Curr Top Microbiol Immunol 206:67–83PubMed
32.
go back to reference Westall FC (2006) Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 44:2099–2104PubMedCrossRef Westall FC (2006) Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 44:2099–2104PubMedCrossRef
33.
go back to reference Mohindru M, Kang B, Kim BS (2006) Initial capsid-specific CD4(+) T cell responses protect against Theiler’s murine encephalomyelitisvirus-induced demyelinating disease. Eur J Immunol 36:2106–2115PubMedCrossRef Mohindru M, Kang B, Kim BS (2006) Initial capsid-specific CD4(+) T cell responses protect against Theiler’s murine encephalomyelitisvirus-induced demyelinating disease. Eur J Immunol 36:2106–2115PubMedCrossRef
34.
go back to reference McCoy L, Tsunoda I, Fujinami RS (2006) Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39:9–19PubMedCrossRef McCoy L, Tsunoda I, Fujinami RS (2006) Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39:9–19PubMedCrossRef
35.
go back to reference Jun S, Gilmore W, Callis G, Rynda A, Haddad A, Pascual DW (2005) A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol 175:6733–6740PubMed Jun S, Gilmore W, Callis G, Rynda A, Haddad A, Pascual DW (2005) A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol 175:6733–6740PubMed
36.
go back to reference Sewell DL, Reinke EK, Co DO et al (2003) Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis. Clin Diagn Lab Immunol 10:564–572PubMedCrossRef Sewell DL, Reinke EK, Co DO et al (2003) Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis. Clin Diagn Lab Immunol 10:564–572PubMedCrossRef
37.
go back to reference Green J, Casabonne D, Newton R (2004) Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med 21:507–514PubMedCrossRef Green J, Casabonne D, Newton R (2004) Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med 21:507–514PubMedCrossRef
38.
go back to reference Filippi C, von Herrath M (2005) How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol 233:125–132PubMedCrossRef Filippi C, von Herrath M (2005) How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol 233:125–132PubMedCrossRef
39.
go back to reference Jun HS, Yoon JW (2004) Viral Infections and type1 diabetes. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam, pp 229–249 Jun HS, Yoon JW (2004) Viral Infections and type1 diabetes. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. 1st edn. Elsevier, Amsterdam, pp 229–249
40.
go back to reference Altobelli E, Petrocelli R, Verrotti A, Valenti M (2003) Infections and risk of type I diabetes in childhood: a population-based case-control study. Eur J Epidemiol 18:425–430PubMedCrossRef Altobelli E, Petrocelli R, Verrotti A, Valenti M (2003) Infections and risk of type I diabetes in childhood: a population-based case-control study. Eur J Epidemiol 18:425–430PubMedCrossRef
41.
go back to reference King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265–277PubMedCrossRef King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265–277PubMedCrossRef
42.
go back to reference Gronski MA, Boulter JM, Moskophidis D et al (2004) TCR affinity and negative regulation limit autoimmunity. Nat Med 10:1234–1239PubMedCrossRef Gronski MA, Boulter JM, Moskophidis D et al (2004) TCR affinity and negative regulation limit autoimmunity. Nat Med 10:1234–1239PubMedCrossRef
43.
go back to reference Serreze DV, Wasserfall C, Ottendorfer EW et al (2005) Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 79:1045–1052PubMedCrossRef Serreze DV, Wasserfall C, Ottendorfer EW et al (2005) Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon. J Virol 79:1045–1052PubMedCrossRef
44.
go back to reference Alyanakian MA, Grela F, Aumeunier A et al (2006) Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 55:179–185PubMedCrossRef Alyanakian MA, Grela F, Aumeunier A et al (2006) Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 55:179–185PubMedCrossRef
45.
go back to reference Raine T, Zaccone P, Mastroeni P, Cooke A (2006) Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 177:2224–2233PubMed Raine T, Zaccone P, Mastroeni P, Cooke A (2006) Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 177:2224–2233PubMed
46.
go back to reference Saunders KA, Raine T, Cooke A, Lawrence CE (2006) Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 75:397–407PubMedCrossRef Saunders KA, Raine T, Cooke A, Lawrence CE (2006) Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 75:397–407PubMedCrossRef
47.
go back to reference Harley JB, James JA (2006) Epstein–Barr virus infection induces lupus autoimmunity. Bull Hosp Joint Dis 64:45–50 Harley JB, James JA (2006) Epstein–Barr virus infection induces lupus autoimmunity. Bull Hosp Joint Dis 64:45–50
48.
go back to reference Harley JB, Harley IT, Guthridge JM, James JA (2006) The curiously suspicious: a role for Epstein–Barr virus in lupus. Lupus 15:768–777PubMedCrossRef Harley JB, Harley IT, Guthridge JM, James JA (2006) The curiously suspicious: a role for Epstein–Barr virus in lupus. Lupus 15:768–777PubMedCrossRef
49.
go back to reference James JA, Neas BR, Moser KL et al (2001) Systemic lupus erythematosus in adults is associated with previous Epstein–Barr virus exposure. Arthritis Rheum 44:1122–1136PubMedCrossRef James JA, Neas BR, Moser KL et al (2001) Systemic lupus erythematosus in adults is associated with previous Epstein–Barr virus exposure. Arthritis Rheum 44:1122–1136PubMedCrossRef
50.
go back to reference Parks CG, Cooper GS, Hudson LL et al (2005) Association of Epstein–Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148–1159PubMedCrossRef Parks CG, Cooper GS, Hudson LL et al (2005) Association of Epstein–Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148–1159PubMedCrossRef
51.
go back to reference Chen CJ, Lin KH, Lin SC et al (2005) High prevalence of immunoglobulin A antibody against Epstein–Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 32:44–47PubMed Chen CJ, Lin KH, Lin SC et al (2005) High prevalence of immunoglobulin A antibody against Epstein–Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 32:44–47PubMed
52.
go back to reference Mockridge CI, Rahman A, Buchan S et al (2004) Common patterns of B cell perturbation and expanded V4–34 immunoglobulin gene usage in autoimmunity and infection. Autoimmunity 37:9–15PubMedCrossRef Mockridge CI, Rahman A, Buchan S et al (2004) Common patterns of B cell perturbation and expanded V4–34 immunoglobulin gene usage in autoimmunity and infection. Autoimmunity 37:9–15PubMedCrossRef
53.
go back to reference Bengtsson A, Widell A, Elmstahl S, Sturfelt G (2000) No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis 59:64–66PubMedCrossRef Bengtsson A, Widell A, Elmstahl S, Sturfelt G (2000) No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis 59:64–66PubMedCrossRef
54.
go back to reference Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S (1999) Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol 14:73–77PubMedCrossRef Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S (1999) Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol 14:73–77PubMedCrossRef
55.
go back to reference Seishima M, Oyama Z, Yamamura M (2003) Two-year follow-up study after human parvovirus B19 infection. Dermatology 206:192–196PubMedCrossRef Seishima M, Oyama Z, Yamamura M (2003) Two-year follow-up study after human parvovirus B19 infection. Dermatology 206:192–196PubMedCrossRef
56.
go back to reference Hrycek A, Kusmierz D, Mazurek U, Wilczok T (2005) Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity 38:487–491PubMedCrossRef Hrycek A, Kusmierz D, Mazurek U, Wilczok T (2005) Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity 38:487–491PubMedCrossRef
57.
go back to reference Wang H, Nicholas MW, Conway KL et al (2006) EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177:27932–802 Wang H, Nicholas MW, Conway KL et al (2006) EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177:27932–802
58.
go back to reference Chang M, Pan MR, Chen DY, Lan JL (2006) Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice. Clin Exp Immunol 143:167–179PubMedCrossRef Chang M, Pan MR, Chen DY, Lan JL (2006) Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice. Clin Exp Immunol 143:167–179PubMedCrossRef
59.
go back to reference Mittleman BB, Morse HC 3rd, Payne SM, Shearer GM, Mozes E (1996) Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection. J Clin Immunol 16:230–236PubMedCrossRef Mittleman BB, Morse HC 3rd, Payne SM, Shearer GM, Mozes E (1996) Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection. J Clin Immunol 16:230–236PubMedCrossRef
60.
go back to reference Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M (2004) Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 58:325–337PubMedCrossRef Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M (2004) Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 58:325–337PubMedCrossRef
61.
go back to reference Satoh M, Hamilton KJ, Ajmani AK et al (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 157:3200–3206PubMed Satoh M, Hamilton KJ, Ajmani AK et al (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 157:3200–3206PubMed
62.
go back to reference Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983–986PubMedCrossRef Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983–986PubMedCrossRef
63.
go back to reference Danesh J, Whincup P, Walker M (2003) Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J 24:881PubMedCrossRef Danesh J, Whincup P, Walker M (2003) Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J 24:881PubMedCrossRef
64.
go back to reference Degre M (2002) Has cytomegalovirus infection any role in the development of atherosclerosis? Clin Microbiol Infect 8:191–195PubMedCrossRef Degre M (2002) Has cytomegalovirus infection any role in the development of atherosclerosis? Clin Microbiol Infect 8:191–195PubMedCrossRef
65.
go back to reference Beck JD, Eke P, Lin D et al (2005) Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183:342–348PubMedCrossRef Beck JD, Eke P, Lin D et al (2005) Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults. Atherosclerosis 183:342–348PubMedCrossRef
66.
go back to reference Frostegård J (2004) Infection and atherosclerosis. In: Shoenfeld Y, Rose NR (eds) Infections and autoimmunity. Elsevier, Amsterdam, pp 701–709CrossRef Frostegård J (2004) Infection and atherosclerosis. In: Shoenfeld Y, Rose NR (eds) Infections and autoimmunity. Elsevier, Amsterdam, pp 701–709CrossRef
67.
go back to reference Lunardi C, Bason C, Corrocher R, Puccetti A (2005) Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol 26:19–24PubMedCrossRef Lunardi C, Bason C, Corrocher R, Puccetti A (2005) Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol 26:19–24PubMedCrossRef
68.
go back to reference Vliegen I, Herngreen SB, Grauls GE, Bruggeman CA, Stassen FR (2005) Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181:39–44PubMedCrossRef Vliegen I, Herngreen SB, Grauls GE, Bruggeman CA, Stassen FR (2005) Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis 181:39–44PubMedCrossRef
69.
go back to reference Lalla E, Lamster IB, Hofmann MA et al (2003) Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23:1405–1411PubMedCrossRef Lalla E, Lamster IB, Hofmann MA et al (2003) Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23:1405–1411PubMedCrossRef
70.
go back to reference Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK (2001) Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103:2834283–2834288 Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK (2001) Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103:2834283–2834288
71.
go back to reference Binder CJ, Horkko S, Dewan A et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:736–743PubMedCrossRef Binder CJ, Horkko S, Dewan A et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:736–743PubMedCrossRef
72.
go back to reference Cervera R, Asherson RA, Acevedo ML et al (2004) Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63:1312–1317PubMedCrossRef Cervera R, Asherson RA, Acevedo ML et al (2004) Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63:1312–1317PubMedCrossRef
73.
go back to reference Uthman I, Tabbarah Z, Gharavi AE (1999) Hughes syndrome associated with cytomegalovirus infection. Lupus 8:775–777PubMedCrossRef Uthman I, Tabbarah Z, Gharavi AE (1999) Hughes syndrome associated with cytomegalovirus infection. Lupus 8:775–777PubMedCrossRef
74.
go back to reference van Hal S, Senanayake S, Hardiman R (2005) Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein–Barr virus infection. J Clin Virol 32:245–247PubMedCrossRef van Hal S, Senanayake S, Hardiman R (2005) Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein–Barr virus infection. J Clin Virol 32:245–247PubMedCrossRef
75.
go back to reference Faghiri Z, Wilson WA, Taheri F, Barton EN, Morgan OS, Gharavi AE (1999) Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis. Lupus 8:210–214PubMedCrossRef Faghiri Z, Wilson WA, Taheri F, Barton EN, Morgan OS, Gharavi AE (1999) Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis. Lupus 8:210–214PubMedCrossRef
76.
go back to reference Blank M, Asherson RA, Cervera R, Shoenfeld Y (2004) Antiphospholipid syndrome infectious origin. J Clin Immunol 24:12–23PubMedCrossRef Blank M, Asherson RA, Cervera R, Shoenfeld Y (2004) Antiphospholipid syndrome infectious origin. J Clin Immunol 24:12–23PubMedCrossRef
77.
go back to reference Blank M, Krause I, Magrini L et al (2006) Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford, England) 45:833–841CrossRef Blank M, Krause I, Magrini L et al (2006) Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford, England) 45:833–841CrossRef
78.
go back to reference Cervera R, Gomez-Puerta JA, Espinosa G, Cucho M, Font J (2003) “CAPS registry”. A review of 200 cases from the International Registry of patients with the Catastrophic Antiphospholipid Syndrome (CAPS). Ann Rheum Dis 62(Suppl 1):88 Cervera R, Gomez-Puerta JA, Espinosa G, Cucho M, Font J (2003) “CAPS registry”. A review of 200 cases from the International Registry of patients with the Catastrophic Antiphospholipid Syndrome (CAPS). Ann Rheum Dis 62(Suppl 1):88
79.
go back to reference Bucciarelli S, Espinosa G, Cervera R et al (2006) Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568–2576PubMedCrossRef Bucciarelli S, Espinosa G, Cervera R et al (2006) Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568–2576PubMedCrossRef
80.
go back to reference Gharavi EE, Chaimovich H, Cucurull E et al (1999) Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 8:449–455PubMedCrossRef Gharavi EE, Chaimovich H, Cucurull E et al (1999) Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 8:449–455PubMedCrossRef
81.
go back to reference Zampieri S, Ghirardello A, Iaccarino L et al (2006) Polymyositis–dermatomyositis and infections. Autoimmunity 39:191–196PubMedCrossRef Zampieri S, Ghirardello A, Iaccarino L et al (2006) Polymyositis–dermatomyositis and infections. Autoimmunity 39:191–196PubMedCrossRef
82.
go back to reference Nishikai M (1994) Coxsackievirus infection and the development of polymyositis/dermatomyositis. Rheumatol Int 14:43–46PubMedCrossRef Nishikai M (1994) Coxsackievirus infection and the development of polymyositis/dermatomyositis. Rheumatol Int 14:43–46PubMedCrossRef
83.
go back to reference Mamyrova G, Rider LG, Haagenson L, Wong S, Brown KE (2005) Parvovirus B19 and onset of juvenile dermatomyositis. J Am Med Assoc 294:2170–2171CrossRef Mamyrova G, Rider LG, Haagenson L, Wong S, Brown KE (2005) Parvovirus B19 and onset of juvenile dermatomyositis. J Am Med Assoc 294:2170–2171CrossRef
84.
go back to reference Tam PE, Weber-Sanders ML, Messner RP (2003) Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol 77:11849–11854PubMedCrossRef Tam PE, Weber-Sanders ML, Messner RP (2003) Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol 77:11849–11854PubMedCrossRef
85.
go back to reference Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT (2006) Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80:737–749PubMedCrossRef Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT (2006) Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80:737–749PubMedCrossRef
86.
go back to reference Andrade SG, Campos RF, Sobral KS, Magalhaes JB, Guedes RS, Guerreiro ML (2006) Reinfections with strains of Trypanosoma cruzi, of different biodemes as a factor of aggravation of myocarditis and myositis in mice. Rev Soc Bras Med Trop 39:1–8PubMed Andrade SG, Campos RF, Sobral KS, Magalhaes JB, Guedes RS, Guerreiro ML (2006) Reinfections with strains of Trypanosoma cruzi, of different biodemes as a factor of aggravation of myocarditis and myositis in mice. Rev Soc Bras Med Trop 39:1–8PubMed
87.
go back to reference Ohtsuka T, Yamazaki S (2005) Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue. Br J Dermatol 152:1078–1080PubMedCrossRef Ohtsuka T, Yamazaki S (2005) Altered prevalence of human parvovirus B19 component genes in systemic sclerosis skin tissue. Br J Dermatol 152:1078–1080PubMedCrossRef
88.
go back to reference Namboodiri AM, Rocca KM, Kuwana M, Pandey JP (2006) Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Clin Exp Rheumatol 24:176–178PubMed Namboodiri AM, Rocca KM, Kuwana M, Pandey JP (2006) Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Clin Exp Rheumatol 24:176–178PubMed
89.
go back to reference Kalabay L, Fekete B, Czirjak L et al (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250–256PubMedCrossRef Kalabay L, Fekete B, Czirjak L et al (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250–256PubMedCrossRef
90.
go back to reference Lunardi C, Bason C, Navone R et al (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183–1186PubMedCrossRef Lunardi C, Bason C, Navone R et al (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183–1186PubMedCrossRef
91.
go back to reference Gavanescu I, Pihan G, Halilovic E, Szomolanyi-Tsuda E, Welsh RM, Doxsey S (2004) Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice. Clin Exp Immunol 137:288–297PubMedCrossRef Gavanescu I, Pihan G, Halilovic E, Szomolanyi-Tsuda E, Welsh RM, Doxsey S (2004) Mycoplasma infection induces a scleroderma-like centrosome autoantibody response in mice. Clin Exp Immunol 137:288–297PubMedCrossRef
92.
go back to reference Rodriguez-Pla A, Stone JH (2006) Vasculitis and systemic infections. Curr Opin Rheumatol 18:39–47PubMedCrossRef Rodriguez-Pla A, Stone JH (2006) Vasculitis and systemic infections. Curr Opin Rheumatol 18:39–47PubMedCrossRef
93.
go back to reference Eden A, Mahr A, Servant A et al (2003) Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study. Rheumatology (Oxford) 42:660–664CrossRef Eden A, Mahr A, Servant A et al (2003) Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study. Rheumatology (Oxford) 42:660–664CrossRef
94.
go back to reference Helweg-Larsen J, Tarp B, Obel N, Baslund B (2002) No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 41:445–449CrossRef Helweg-Larsen J, Tarp B, Obel N, Baslund B (2002) No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 41:445–449CrossRef
95.
go back to reference Chang LY, Chiang BL, Kao CL et al (2006) Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis 193:283–286PubMedCrossRef Chang LY, Chiang BL, Kao CL et al (2006) Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis 193:283–286PubMedCrossRef
96.
go back to reference Robinson JL, Spady DW, Prasad E, McColl D, Artsob H (2005) Bartonella seropositivity in children with Henoch–Schonlein purpura. BMC Infec Dis 5(1):21CrossRef Robinson JL, Spady DW, Prasad E, McColl D, Artsob H (2005) Bartonella seropositivity in children with Henoch–Schonlein purpura. BMC Infec Dis 5(1):21CrossRef
97.
go back to reference Steed AL, Barton ES, Tibbetts SA et al (2006) Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 80:192–200PubMedCrossRef Steed AL, Barton ES, Tibbetts SA et al (2006) Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 80:192–200PubMedCrossRef
98.
go back to reference Shinohara H, Nagi-Miura N, Ishibashi K et al (2006) Beta-mannosyl linkages negatively regulate anaphylaxis and vasculitis in mice, induced by CAWS, fungal PAMPS composed of mannoprotein-beta-glucan complex secreted by Candida albicans. Biol Pharm Bull 29:1854–1861PubMedCrossRef Shinohara H, Nagi-Miura N, Ishibashi K et al (2006) Beta-mannosyl linkages negatively regulate anaphylaxis and vasculitis in mice, induced by CAWS, fungal PAMPS composed of mannoprotein-beta-glucan complex secreted by Candida albicans. Biol Pharm Bull 29:1854–1861PubMedCrossRef
99.
go back to reference Malipiero U, Koedel U, Pfister HW et al (2006) TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis. Brain 129(Pt 9):2404–2415PubMedCrossRef Malipiero U, Koedel U, Pfister HW et al (2006) TGFbeta receptor II gene deletion in leucocytes prevents cerebral vasculitis in bacterial meningitis. Brain 129(Pt 9):2404–2415PubMedCrossRef
100.
go back to reference Huugen D, Xiao H, van Esch A et al (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167:47–58PubMed Huugen D, Xiao H, van Esch A et al (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167:47–58PubMed
101.
go back to reference Gottenberg JE, Pallier C, Ittah M et al (2006) Failure to confirm coxsackievirus infection in primary Sjogren's syndrome. Arthritis Rheum 54:2026–2028PubMedCrossRef Gottenberg JE, Pallier C, Ittah M et al (2006) Failure to confirm coxsackievirus infection in primary Sjogren's syndrome. Arthritis Rheum 54:2026–2028PubMedCrossRef
102.
go back to reference Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjogren’s syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum 41:2175–2184PubMedCrossRef Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjogren’s syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum 41:2175–2184PubMedCrossRef
103.
go back to reference Watanabe S, Suzuki K, Kawauchi Y et al (2003) Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus. Clin Immunol 109:212–223PubMedCrossRef Watanabe S, Suzuki K, Kawauchi Y et al (2003) Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus. Clin Immunol 109:212–223PubMedCrossRef
104.
go back to reference Corapcioglu D, Tonyukuk V, Kiyan M et al (2002) Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid 12:613–617PubMedCrossRef Corapcioglu D, Tonyukuk V, Kiyan M et al (2002) Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid 12:613–617PubMedCrossRef
105.
go back to reference Maki-Ikola O, Heesemann J, Toivanen A, Granfors K (1997) High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int 16:227–229PubMedCrossRef Maki-Ikola O, Heesemann J, Toivanen A, Granfors K (1997) High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int 16:227–229PubMedCrossRef
106.
go back to reference Hansen PS, Wenzel BE, Brix TH, Hegedus L (2006) Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study. Clin Exp Immunol 146:32–38PubMedCrossRef Hansen PS, Wenzel BE, Brix TH, Hegedus L (2006) Yersinia enterocolitica infection does not confer an increased risk of thyroid antibodies: evidence from a Danish twin study. Clin Exp Immunol 146:32–38PubMedCrossRef
107.
go back to reference Mandac JC, Chaudhry S, Sherman KE, Tomer Y (2006) The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (Baltimore) 43:661–672 Mandac JC, Chaudhry S, Sherman KE, Tomer Y (2006) The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (Baltimore) 43:661–672
108.
go back to reference Minelli R, Coiro V, Valli MA et al (2005) Graves’ disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection. J Investig Med 53:26–30PubMedCrossRef Minelli R, Coiro V, Valli MA et al (2005) Graves’ disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection. J Investig Med 53:26–30PubMedCrossRef
109.
go back to reference Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y (2004) TSH receptor-adenovirus-induced Graves’ hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm. Clin Exp Immunol 138:417–422PubMedCrossRef Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y (2004) TSH receptor-adenovirus-induced Graves’ hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm. Clin Exp Immunol 138:417–422PubMedCrossRef
110.
go back to reference Saitoh O, Nagayama Y (2006) Regulation of Graves’ hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147:2417–2422PubMedCrossRef Saitoh O, Nagayama Y (2006) Regulation of Graves’ hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147:2417–2422PubMedCrossRef
111.
go back to reference Harii N, Lewis CJ, Vasko V et al (2005) Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto’s autoimmune thyroiditis. Mol Endocrinol (Baltimore) 19:1231–1250 Harii N, Lewis CJ, Vasko V et al (2005) Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto’s autoimmune thyroiditis. Mol Endocrinol (Baltimore) 19:1231–1250
112.
go back to reference Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B (2004) Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves’ hyperthyroidism. J Immunol 173:2167–2173PubMed Nagayama Y, Watanabe K, Niwa M, McLachlan SM, Rapoport B (2004) Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves’ hyperthyroidism. J Immunol 173:2167–2173PubMed
113.
go back to reference Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM (2006) Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39:41–54PubMedCrossRef Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM (2006) Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39:41–54PubMedCrossRef
114.
115.
go back to reference Kotilainen P, Lehtopolku M, Hakanen AJ (2006) Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review. Scand J Infec Dis 38(6–7):549–552CrossRef Kotilainen P, Lehtopolku M, Hakanen AJ (2006) Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review. Scand J Infec Dis 38(6–7):549–552CrossRef
116.
go back to reference Fairweather D, Frisancho-Kiss S, Yusung SA et al (2005) IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 174:261–269PubMed Fairweather D, Frisancho-Kiss S, Yusung SA et al (2005) IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol 174:261–269PubMed
117.
go back to reference Omura T, Yoshiyama M, Hayashi T et al (2005) Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 96:148–150PubMedCrossRef Omura T, Yoshiyama M, Hayashi T et al (2005) Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 96:148–150PubMedCrossRef
118.
go back to reference Richer MJ, Fang D, Shanina I, Horwitz MS (2006) Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis. Clin Immunol 121(3):339–349PubMedCrossRef Richer MJ, Fang D, Shanina I, Horwitz MS (2006) Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis. Clin Immunol 121(3):339–349PubMedCrossRef
119.
go back to reference Afanasyeva M, Rose NR (2004) Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam Afanasyeva M, Rose NR (2004) Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam
120.
go back to reference Green C, Elliott L, Beaudoin C, Bernstein CN (2006) A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 164:615–623 (discussion 24–28)PubMedCrossRef Green C, Elliott L, Beaudoin C, Bernstein CN (2006) A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 164:615–623 (discussion 24–28)PubMedCrossRef
121.
go back to reference Oliveira AG, Rocha GA, Rocha AM et al (2006) Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn’s disease. Helicobacter 11:2–9PubMedCrossRef Oliveira AG, Rocha GA, Rocha AM et al (2006) Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn’s disease. Helicobacter 11:2–9PubMedCrossRef
122.
go back to reference Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z (2004) Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease—antibiotic use in the history does not play a significant role. Helicobacter 9:278–283PubMedCrossRef Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z (2004) Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease—antibiotic use in the history does not play a significant role. Helicobacter 9:278–283PubMedCrossRef
123.
go back to reference Saebo A, Vik E, Lange OJ, Matuszkiewicz L (2005) Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection. Eur J Intern Med 16:176–182PubMedCrossRef Saebo A, Vik E, Lange OJ, Matuszkiewicz L (2005) Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection. Eur J Intern Med 16:176–182PubMedCrossRef
124.
go back to reference Romero C, Hamdi A, Valentine JF, Naser SA (2005) Evaluation of surgical tissue from patients with Crohn’s disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis 11:116–125PubMedCrossRef Romero C, Hamdi A, Valentine JF, Naser SA (2005) Evaluation of surgical tissue from patients with Crohn’s disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis 11:116–125PubMedCrossRef
125.
go back to reference Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A (2006) Does cross-reactivity between Mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn’s disease? Gastroenterology 131:85–96PubMedCrossRef Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A (2006) Does cross-reactivity between Mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn’s disease? Gastroenterology 131:85–96PubMedCrossRef
126.
go back to reference Weinstock JV (2004) Inflammatory bowel disease. In: Shoenfeld Y, Rose NR (eds) Infection and Autoimmunity. 1st edn. Elsevier, Amsterdam, pp 649–673 Weinstock JV (2004) Inflammatory bowel disease. In: Shoenfeld Y, Rose NR (eds) Infection and Autoimmunity. 1st edn. Elsevier, Amsterdam, pp 649–673
127.
go back to reference Gionchetti P, Rizzello F, Lammers KM et al (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306–3313PubMed Gionchetti P, Rizzello F, Lammers KM et al (2006) Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 12:3306–3313PubMed
128.
go back to reference Sydora BC, Tavernini MM, Doyle JS, Fedorak RN (2005) Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response. Dig Dis Sci 50:905–913PubMedCrossRef Sydora BC, Tavernini MM, Doyle JS, Fedorak RN (2005) Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response. Dig Dis Sci 50:905–913PubMedCrossRef
129.
go back to reference Moreels TG, Nieuwendijk RJ, De Man JG et al (2004) Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 53:99–107PubMedCrossRef Moreels TG, Nieuwendijk RJ, De Man JG et al (2004) Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats. Gut 53:99–107PubMedCrossRef
130.
go back to reference Hunter MM, Wang A, Hirota CL, McKay DM (2005) Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 174:7368–7375PubMed Hunter MM, Wang A, Hirota CL, McKay DM (2005) Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 174:7368–7375PubMed
131.
go back to reference Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825–832PubMedCrossRef Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825–832PubMedCrossRef
132.
go back to reference Szyper-Kravitz M, Shoenfeld Y (2005) Thrombocytopenic conditions—autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT and APS. Am J Hematol 80:232–242CrossRef Szyper-Kravitz M, Shoenfeld Y (2005) Thrombocytopenic conditions—autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT and APS. Am J Hematol 80:232–242CrossRef
133.
go back to reference Suzuki T, Matsushima M, Masui A et al (2005) Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura—a randomized controlled trial. Am J Gastroenterol 100:1265–1270PubMedCrossRef Suzuki T, Matsushima M, Masui A et al (2005) Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura—a randomized controlled trial. Am J Gastroenterol 100:1265–1270PubMedCrossRef
134.
go back to reference Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D (2005) Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 118:414–419PubMedCrossRef Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D (2005) Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 118:414–419PubMedCrossRef
135.
go back to reference Musaji A, Meite M, Detalle L et al (2005) Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia. Autoimmunity Rev 4:247–252CrossRef Musaji A, Meite M, Detalle L et al (2005) Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia. Autoimmunity Rev 4:247–252CrossRef
136.
go back to reference Li Z, Nardi MA, Karpatkin S (2005) Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood 106:572–576PubMedCrossRef Li Z, Nardi MA, Karpatkin S (2005) Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood 106:572–576PubMedCrossRef
137.
go back to reference van Sorge NM, van den Berg LH, Jansen MD, van de Winkel JGJ, van der Pol WL (2004) Infection and Guillain-Barré syndrome. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 591–612 van Sorge NM, van den Berg LH, Jansen MD, van de Winkel JGJ, van der Pol WL (2004) Infection and Guillain-Barré syndrome. In: Shoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 591–612
138.
go back to reference Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O'Brien SJ (2006) Incidence of Guillain–Barre syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis 194:95–97PubMedCrossRef Tam CC, Rodrigues LC, Petersen I, Islam A, Hayward A, O'Brien SJ (2006) Incidence of Guillain–Barre syndrome among patients with Campylobacter infection: a general practice research database study. J Infect Dis 194:95–97PubMedCrossRef
139.
go back to reference Kountouras J, Deretzi G, Zavos C et al (2005) Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 12:139–143PubMedCrossRef Kountouras J, Deretzi G, Zavos C et al (2005) Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 12:139–143PubMedCrossRef
140.
go back to reference Watanabe K, Kim S, Nishiguchi M, Suzuki H, Watarai M (2005) Brucella melitensis infection associated with Guillain–Barre syndrome through molecular mimicry of host structures. FEMS Iimmunol Med Microbiol 45:121–127CrossRef Watanabe K, Kim S, Nishiguchi M, Suzuki H, Watarai M (2005) Brucella melitensis infection associated with Guillain–Barre syndrome through molecular mimicry of host structures. FEMS Iimmunol Med Microbiol 45:121–127CrossRef
141.
go back to reference Godschalk PC, Heikema AP, Gilbert M et al (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain–Barre syndrome. J Clin Invest 114:1659–1665PubMed Godschalk PC, Heikema AP, Gilbert M et al (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain–Barre syndrome. J Clin Invest 114:1659–1665PubMed
142.
go back to reference Geier MR, Geier DA, Zahalsky AC (2003) Influenza vaccination and Guillain–Barre syndrome. Clin Immunol 107:116–121PubMedCrossRef Geier MR, Geier DA, Zahalsky AC (2003) Influenza vaccination and Guillain–Barre syndrome. Clin Immunol 107:116–121PubMedCrossRef
143.
go back to reference Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L (2005) How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24:101–109PubMedCrossRef Fae KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L (2005) How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun 24:101–109PubMedCrossRef
144.
go back to reference Fae K, Kalil J, Toubert A, Guilherme L (2004) Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol 40:1129–1135PubMedCrossRef Fae K, Kalil J, Toubert A, Guilherme L (2004) Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol 40:1129–1135PubMedCrossRef
145.
go back to reference Guilherme L, Fae K, Oshiro SE, Kalil J (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 7:1–15PubMedCrossRef Guilherme L, Fae K, Oshiro SE, Kalil J (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 7:1–15PubMedCrossRef
146.
go back to reference Olive C, Ho MF, Dyer J et al (2006) Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 193:1666–1676PubMedCrossRef Olive C, Ho MF, Dyer J et al (2006) Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 193:1666–1676PubMedCrossRef
147.
go back to reference Giovannoni G (2006) PANDAS: overview of the hypothesis. Adv Neurol 99:159–165PubMed Giovannoni G (2006) PANDAS: overview of the hypothesis. Adv Neurol 99:159–165PubMed
148.
go back to reference Perlmutter SJ, Leitman SF, Garvey MA et al (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive–compulsive disorder and tic disorders in childhood. Lancet 354:1153–1158PubMedCrossRef Perlmutter SJ, Leitman SF, Garvey MA et al (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive–compulsive disorder and tic disorders in childhood. Lancet 354:1153–1158PubMedCrossRef
149.
go back to reference Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH (2004) Anti-basal ganglia antibodies in PANDAS. Mov Disord 19:406–415PubMedCrossRef Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH (2004) Anti-basal ganglia antibodies in PANDAS. Mov Disord 19:406–415PubMedCrossRef
150.
go back to reference Jablonka E, Lamb M (2005) Evolution in four dimensions, 1st edn. MIT Press, Boston Jablonka E, Lamb M (2005) Evolution in four dimensions, 1st edn. MIT Press, Boston
Metadata
Title
Infections and Autoimmunity: A Panorama
Authors
V. Pordeus
M. Szyper-Kravitz
R. A. Levy
N. M. Vaz
Y. Shoenfeld
Publication date
01-06-2008
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2008
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-007-8048-8

Other articles of this Issue 3/2008

Clinical Reviews in Allergy & Immunology 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine